These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26087061)

  • 41. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis.
    Amarneh B; Corbin CJ; Peterson JA; Simpson ER; Graham-Lorence S
    Mol Endocrinol; 1993 Dec; 7(12):1617-24. PubMed ID: 8145767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC; Watson DM; So OY
    Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase.
    Guengerich FP
    Arch Biochem Biophys; 2005 Aug; 440(2):204-11. PubMed ID: 16055078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
    Chen HC; Swenson RP
    Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testosterone complex and non-steroidal ligands of human aromatase.
    Ghosh D; Egbuta C; Lo J
    J Steroid Biochem Mol Biol; 2018 Jul; 181():11-19. PubMed ID: 29476820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A three-dimensional model of CYP19 aromatase for structure-based drug design.
    Karkola S; Höltje HD; Wähälä K
    J Steroid Biochem Mol Biol; 2007; 105(1-5):63-70. PubMed ID: 17583493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conformational dynamics and the energetics of protein--ligand interactions: role of interdomain loop in human cytochrome P450 reductase.
    Grunau A; Geraki K; Grossmann JG; Gutierrez A
    Biochemistry; 2007 Jul; 46(28):8244-55. PubMed ID: 17580970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformational Equilibrium of NADPH-Cytochrome P450 Oxidoreductase Is Essential for Heme Oxygenase Reaction.
    Sugishima M; Taira J; Sagara T; Nakao R; Sato H; Noguchi M; Fukuyama K; Yamamoto K; Yasunaga T; Sakamoto H
    Antioxidants (Basel); 2020 Jul; 9(8):. PubMed ID: 32731542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Working at the membrane interface: Ligand-induced changes in dynamic conformation and oligomeric structure in human aromatase.
    Di Nardo G; Cimicata G; Baravalle R; Dell'Angelo V; Ciaramella A; Catucci G; Ugliengo P; Gilardi G
    Biotechnol Appl Biochem; 2018 Jan; 65(1):46-53. PubMed ID: 28926141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformational change induced by electron transfer in a monolayer of cytochrome P450 reductase adsorbed at the Au(110)-phosphate buffer interface.
    Weightman P; Smith CI; Convery JH; Harrison P; Khara B; Scrutton NS
    Phys Rev E Stat Nonlin Soft Matter Phys; 2013 Sep; 88(3):032715. PubMed ID: 24125302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors.
    van Dijk M; Ter Laak AM; Wichard JD; Capoferri L; Vermeulen NPE; Geerke DP
    J Chem Inf Model; 2017 Sep; 57(9):2294-2308. PubMed ID: 28776988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-Translational Regulation of CYP450s Metabolism As Revealed by All-Atoms Simulations of the Aromatase Enzyme.
    Ritacco I; Spinello A; Ippoliti E; Magistrato A
    J Chem Inf Model; 2019 Jun; 59(6):2930-2940. PubMed ID: 31033287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytochrome P450 differences in normal and imposex-affected female whelk Buccinum undatum from the open North Sea.
    Santos MM; ten Hallers-Tjabbes CC; Vieira N; Boon JP; Porte C
    Mar Environ Res; 2002; 54(3-5):661-5. PubMed ID: 12408632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conformational selection is present in ligand binding to cytochrome P450 19A1 lipoprotein nanodiscs.
    Zárate-Pérez F; Hackett JC
    J Inorg Biochem; 2020 Aug; 209():111120. PubMed ID: 32464592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments.
    Chen S; Zhou D
    J Biol Chem; 1994 Jan; 269(2):1564. PubMed ID: 8288624
    [No Abstract]   [Full Text] [Related]  

  • 57. Proceedings of the IX International Aromatase Conference. October 13-16, 2008. Shanghai, China.
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):195-315. PubMed ID: 19900548
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of cholesterol on kinetic parameters for human aromatase (P450 19A1) in phospholipid nanodiscs.
    Sumangala N; Im SC; Valentín-Goyco J; Auchus RJ
    J Inorg Biochem; 2023 Oct; 247():112340. PubMed ID: 37544101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the complex formation, interaction and electron transfer pathway between the "open" conformation of NADPH-cytochrome P450 reductase and aromatase.
    Dai Y; Zhen J; Zhang X; Zhong Y; Liu S; Sun Z; Guo Y; Wu Q
    Steroids; 2015 Sep; 101():116-24. PubMed ID: 26087061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular dynamics simulations give insight into the conformational change, complex formation, and electron transfer pathway for cytochrome P450 reductase.
    Sündermann A; Oostenbrink C
    Protein Sci; 2013 Sep; 22(9):1183-95. PubMed ID: 23832577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.